⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Official Title: A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects With Advanced Malignancies

Study ID: NCT04254107

Study Description

Brief Summary: This trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it is safe for patients with solid tumors and lymphomas. It will study SEA-TGT to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether SEA-TGT works to treat solid tumors and lymphomas. The study will have four parts. Part A of the study will find out how much SEA-TGT should be given to patients. Part B will use the dose found in Part A to find out how safe SEA-TGT is and if it works to treat solid tumors and lymphomas. Part C will study how well SEA-TGT with sasanlimab works to treat solid tumors. Part D will study how well SEA-TGT with brentuximab vedotin works to treat classical Hodgkin lymphoma (cHL).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States

Arizona Oncology Associates, PC - HOPE, Tucson, Arizona, United States

City of Hope, Duarte, California, United States

California Research Institute, Los Angeles, California, United States

University of California, San Francisco | HDFCCC - Hematopoietic Malignancies, San Francisco, California, United States

Yale Cancer Center, New Haven, Connecticut, United States

Johns Hopkins Medical Center, Baltimore, Maryland, United States

Maryland Oncology Hematology, P.A., Rockville, Maryland, United States

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Minnesota Oncology Hematology P.A., Minneapolis, Minnesota, United States

Mayo Clinic Rochester, Rochester, Minnesota, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

Weill Cornell Medicine, New York, New York, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Wake Forest Baptist Medical Center / Wake Forest University, Winston-Salem, North Carolina, United States

University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States

Providence Portland Medical Center, Portland, Oregon, United States

University of Pittsburgh Medical Center (UPMC)/Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Texas Oncology - Austin Midtown, Austin, Texas, United States

Texas Oncology - Baylor Sammons Cancer Center, Dallas, Texas, United States

MD Anderson Cancer Center / University of Texas, Houston, Texas, United States

Texas Oncology - Northeast Texas, Tyler, Texas, United States

Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care, Blacksburg, Virginia, United States

Virginia Cancer Specialists, PC, Fairfax, Virginia, United States

Carbone Cancer Center / University of Wisconsin, Madison, Wisconsin, United States

University of Alberta / Cross Cancer Institute, Edmonton, Alberta, Canada

University Health Network, Princess Margaret Hospital, Toronto, Other, Canada

Institut Gustave Roussy, Villejuif Cedex, Other, France

Istituto Europeo di Oncologia, Milano, Other, Italy

Policlinico Universitario Agostino Gemelli, Rome, Other, Italy

Hospital Universitari Vall d'Hebron, Barcelona, Other, Spain

L'Institut Catala d'Oncologia, L'Hospitalet de Llobregat, Other, Spain

HM Centro Integral Oncologico Clara Campal, Madrid, Other, Spain

Sarah Cannon Research Institute UK, London, Other, United Kingdom

The Royal Marsden Hospital (Surrey), Sutton, Other, United Kingdom

Contact Details

Name: Andres Forero-Torres, MD

Affiliation: Seagen Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: